The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein

Virology

Volumn 242, Issue 2, 1998, Pages 239-245

  Li, Kehan ^a   Chen, Zongyu ^a   Plagemann, Peter ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTERIVIRUS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LOCATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE;

ANIMALIA; ARTERIVIRUS; LACTATE DEHYDROGENASE-ELEVATING VIRUS; RNA VIRUSES;

EID: 0032520596     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.9014     Document Type: Article

References (27)

1. Anderson G. W., Even C., Rowland R. R. R., Palmer G. A., Harty J. T., Plagemann P. G. W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J. Neurovirol. 1:1995a;244-252.
2. Anderson G. W., Palmer G. A., Rowland R. R. R., Even C., Plagemann P. G. W. Infection of central nervous system glial cells by ecotropic murine leukemia virus in C58 and AKR mice andin utero. J. Virol. 69:1995b;308-319.
3. L. Virology. 207:1995;518-527.
4. Brinton-Darnell M., Plagemann P. G. W. Structural and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. J. Virol. 16:1975;420-433.
5. Cafruny W. A., Chan S. P. K., Harty J. T., Yousefi S., Kowalchyk K., McDonald D., Foreman B., Budweg G., Plagemann P. G. W. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res. 5:1986;357-375.
6. Cavanagh D. Nidovirales:CoronaviridaeArteriviridae. Arch. Virol. 142/3:1997;629-633.
7. Chen Z., Plagemann P. G. W. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cells. J. Virol. Meth. 65:1997;227-236.
8. Chen Z., Rowland R. R. R., Anderson G. W., Plagemann P. G. W. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J. Virol. 71:1997;2913-2920.
9. Coutelier J.-P. L., van Roost E., Lambotte P., van Snick J. The murine antibody response to lactate dehydrogenase-elevating virus. J. Gen. Virol. 67:1986;1099-1108.
10. Coutelier J.-P. L., van Snick J. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. J. Gen. Virol. 69:1988;2097-2100.
11. Faaberg K. S., Plagemann P. G. W. The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology. 212:1995;512-525.
12. Faaberg K. S., Plagemann P. G. W. ORF 3 of lactate dehydrogenase-elevating virus encodes a soluble, nonstructural, highly glycosylated, and antigenic protein. Virology. 227:1997;245-261.
13. Faaberg K. S., Even C., Palmer G. A., Plagemann P. G. W. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J. Virol. 69:1995;613-617.
14. Godeny E. K., Chen L., Kumar S. N., Methven S. L., Koonin E. V., Brinton M. A. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology. 194:1993;585-596.
15. Harty J. T., Plagemann P. G. W. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection. J. Virol. 62:1988;3210-3216.
16. Harty J. T., Plagemann P. G. W. Monoclonal antibody protection from age-dependent poliomyelitis: Implications regarding the pathogenesis of lactate dehydrogenase-elevating virus. J. Virol. 64:1990;6257-6262.
17. Martinez D., Brinton M. D., Tachovsky T. G., Phelps A. H. Identification of lactate dehydrogenase-elevating virus as etiological agent of genetically restricted, age-dependent polioencephalomyelitis of mice. Infect. Immun. 27:1980;979-987.
18. Murphy, W. H. Mazur, J. J. Fulton, S. A. 1987, Animal model for motor neuron disease, In, Clinical Neuroimmunology, 135, 155, Blackwell Scientific Publications, Oxford, England.
19. Murphy W. H., Nawrocki J. F., Pease L. R. Age-dependent paralytic viral infection in C58 mice: Possible implication in human neurologic disease. Prog. Brain Res. 59:1983;291-303.
20. Palmer G. A., Kuo L., Chen Z., Faaberg K. S., Plagemann P. G. W. Sequence of genome of lactate dehydrogenase-elevating virus. Heterogeneity between strains P and C. Virology. 209:1995;637-642.
21. Pirzadeh B., Dea S. Monoclonal antibodies to the ORF 5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. J. Gen. Virol. 78:1997;1867-1873.
22. Plagemann, P. G. W. 1996, Lactate dehydrogenase-elevating virus and related viruses, In, Virology, B. N. FieldsD. M. KnipeP. M. Howley, 1105, 1120, Raven Press, New York.
23. Plagemann P. G. W., Gregory K. F., Swim H. E., Chan K. K. W. Plasma lactic dehydrogenase elevating agent of mice: Distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Can. J. Microbiol. 9:1963;75-86.
24. Plagemann P. G. W., Harty J. T., Even C. Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies. Arch. Virol. 123:1992;89-100.
25. Plagemann P. G. W., Moennig V. Lactate dehydrogenase-elevating virus, equine arteritis virus and simian hemorrhagic fever virus: A new group of positive-strand RNA viruses. Adv. Virus Res. 41:1992;99-192.
26. Plagemann P. G. W., Rowland R. R. R., Even C., Faaberg K. S. Lactate dehydrogenase-elevating virus - An ideal persistent virus. Semin. Immunopathol. 17:1995;167-186.
27. Riley V., Lilly F., Huerto E., Bardell D. Transmissible agent associated with 26 types of experimental neoplasms. Science. 132:1960;545-547.